These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5157541)

  • 1. [Hypocholesteremic and hypolipemic effects of p-chlorophenoxy-alpha-isobutyrate of 3-hydroxymethylpyridine hydrochloride].
    Marmo E; Imperatore AM; Caputi A; Cataldi S
    Farmaco Prat; 1971 Oct; 26(10):557-84. PubMed ID: 5157541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol)].
    Marmo E; Caputi AP; Vacca C; Imperatore A; Cataldi S
    Clin Ter; 1974 Mar; 68(6):519-67. PubMed ID: 4831379
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of the hypolipemic, hypocholesteremic and platelet anti-aggregating effects of tibric acid].
    Marmo E; Spadaro R; Vacca C; De Rosa G
    Farmaco Sci; 1975 Aug; 30(08):666-75. PubMed ID: 1149877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
    Azarnoff DL; Svoboda DJ
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolytic action of aluminum bis-alpha-para-chlorophenoxy isobutyrate].
    Daver J; Ripoll S; Du Pasquier JP; Edmond E; Palus JC; Ricoeur M; Aubert D
    Therapie; 1969; 24(3):419-28. PubMed ID: 5399537
    [No Abstract]   [Full Text] [Related]  

  • 7. Tocofibrate (tocopheryl 2-(p-chlorophenoxy) isobutyrate); a new peroxisomotropic compound, and its hypocholesterolemic activity in cholesterol-fed rats.
    Tsurute S; Kibata M; Takano T
    Gen Pharmacol; 1982; 13(4):309-13. PubMed ID: 7129071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic effect of two hypolipidemic drugs in rats.
    Magnusson G; Magnusson O
    Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
    Araki Y; Amagase H
    Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ; Azarnoff DL
    Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Potentiating of lipid lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats.
    Simane Z; Nowak H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R94. PubMed ID: 4276652
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.
    Salvador RA; Haber S; Atkins C; Gommi BW; Welch RM
    Life Sci; 1970 Apr; 9(7):397-407. PubMed ID: 5445848
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacologic study of a hypocholesteremic agent (MG. 46)].
    Nordmann J; Loiseau G; Berthe G; Lohier P; Truchaud M
    Therapie; 1972; 27(2):339-58. PubMed ID: 4673514
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of clofibrate on spontaneous arteriosclerosis in rats.
    Tucker MJ
    Atherosclerosis; 1971; 13(2):255-65. PubMed ID: 4254399
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of magnesium, potassium, antikaliuretic agents and hypocholesteremic agents in cardiac lesion development in rats fed a thrombogenic diet and Na 2 HPO 4 ].
    Savoie LL
    Pathol Biol (Paris); 1972 Oct; 20(19):751-6. PubMed ID: 4343433
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
    Seki K; Fukuda M; Isegawa J; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
    [No Abstract]   [Full Text] [Related]  

  • 18. Lentysine: a new hypolipidemic agent from a mushroom.
    Rokujo T; Kikuchi H; Tensho A; Tsukitani Y; Takenawa T; Yoshida K; Kamiya T
    Life Sci; 1970 Apr; 9(7):379-85. PubMed ID: 5463059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs].
    Kaiser W; Zöllner N
    Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529
    [No Abstract]   [Full Text] [Related]  

  • 20. Alimentary production of gallstones in hamsters. 25. Inhibition of production of cholesterol gallstones by 2-(p-chlorophenoxy)-isobutyric acid ethyl ester (clofibrate).
    Dam H; Prange I; Sondergaard E
    Z Ernahrungswiss; 1972 Jun; 11(2):95-104. PubMed ID: 5050497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.